Pub Date : 2022-05-17DOI: 10.1136/bmjinnov-2021-000882
J. Mier-Alpaño, J. R. B. Cruz, M. Fajardo, Jean Francis Barcena, Emelie Ekblad, Fiona Hazell, Anthony Rosendo Faraon, Ramir Anthony Tumolva Blanco, Sealdi Gonzales, N. Juban, M. Labarda
MierAlpaño JD, et al. BMJ Innov 2022;8:155–160. doi:10.1136/bmjinnov-2021-000882 University of the Philippines Manila, Manila, Philippines Make a Difference Foundation, Malmo, Sweden Zuellig Family Foundation, Paranaque City, Philippines Department of Clinical Epidemiology, College of Medicine, University of the Philippines Manila, Manila, Philippines Department of Medicine, School of Health Sciences, University of the Philippines Manila, Manila, Philippines
{"title":"Facilitating learning exchange and building a community of practice to accelerate social innovation in health","authors":"J. Mier-Alpaño, J. R. B. Cruz, M. Fajardo, Jean Francis Barcena, Emelie Ekblad, Fiona Hazell, Anthony Rosendo Faraon, Ramir Anthony Tumolva Blanco, Sealdi Gonzales, N. Juban, M. Labarda","doi":"10.1136/bmjinnov-2021-000882","DOIUrl":"https://doi.org/10.1136/bmjinnov-2021-000882","url":null,"abstract":"MierAlpaño JD, et al. BMJ Innov 2022;8:155–160. doi:10.1136/bmjinnov-2021-000882 University of the Philippines Manila, Manila, Philippines Make a Difference Foundation, Malmo, Sweden Zuellig Family Foundation, Paranaque City, Philippines Department of Clinical Epidemiology, College of Medicine, University of the Philippines Manila, Manila, Philippines Department of Medicine, School of Health Sciences, University of the Philippines Manila, Manila, Philippines","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"96 1","pages":"155 - 160"},"PeriodicalIF":2.0,"publicationDate":"2022-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86606535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-05-17DOI: 10.1136/bmjinnov-2021-000888
J. R. B. Cruz, J. Mier-Alpaño, Abigail Ruth Mier, Jean Francis Barcena, Arturo M. Ongkeko, Gloria Nenita Velasco, J. Montoya, M. Labarda, N. Juban
{"title":"Institutionalisation of social innovation in health research: the Philippine Gelia Castillo Award","authors":"J. R. B. Cruz, J. Mier-Alpaño, Abigail Ruth Mier, Jean Francis Barcena, Arturo M. Ongkeko, Gloria Nenita Velasco, J. Montoya, M. Labarda, N. Juban","doi":"10.1136/bmjinnov-2021-000888","DOIUrl":"https://doi.org/10.1136/bmjinnov-2021-000888","url":null,"abstract":"","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"19 1","pages":"149 - 154"},"PeriodicalIF":2.0,"publicationDate":"2022-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86464733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-05-03DOI: 10.1136/bmjinnov-2021-000879
M. Al-Kuwari, Asma Ali Al Nuaimi, S. Semaan, John Michael Gibb, J. Abdulmajeed, H. A. Al Romaihi
Introduction Contact tracing is an integral component of the overall public health strategy for controlling the outbreak of infectious diseases such as COVID-19. In addition to the conventional contact tracing, Qatar has implemented Ehteraz, a proximity-tracing mobile phone App using global positioning system and Bluetooth technologies. In this paper, we aim to evaluate the accuracy of Ehteraz as a contact tracing App based on the WHO contact tracing criteria and compare its effectiveness to the traditional human led case investigation. Methods A cross-sectional study was conducted using two databases, including Ehteraz proximity data and swab collection and case investigations reports for the same period. Results 46.9% of contacts identified by the Ehteraz app did not meet WHO duration and distance criteria. Among the 5650 contacts flagged by Ehteraz during the period, 4973 (88.0%) of contacts did not share any known relation with the index case they are linked to. Conclusion The study highlighted the inaccuracy of the Ehteraz tool as its technology enables signals passing through walls, so people in different rooms could be unnecessarily flagged as having had contact. Big segments of the population (eg, Children) do not necessarily use smartphones and are not, therefore, flagged by Ehteraz digital contact tracing App. Similarly, Ehteraz rarely flags close contacts identified by human investigation as Bluetooth is usually turned off in a household or at a workplace. These findings highlight that digital contact tracing would be an efficient public health strategy when integrated to and complementing human investigation.
{"title":"Effectiveness of Ehteraz digital contact tracing app versus conventional contact tracing in managing the outbreak of COVID-19 in the State of Qatar","authors":"M. Al-Kuwari, Asma Ali Al Nuaimi, S. Semaan, John Michael Gibb, J. Abdulmajeed, H. A. Al Romaihi","doi":"10.1136/bmjinnov-2021-000879","DOIUrl":"https://doi.org/10.1136/bmjinnov-2021-000879","url":null,"abstract":"Introduction Contact tracing is an integral component of the overall public health strategy for controlling the outbreak of infectious diseases such as COVID-19. In addition to the conventional contact tracing, Qatar has implemented Ehteraz, a proximity-tracing mobile phone App using global positioning system and Bluetooth technologies. In this paper, we aim to evaluate the accuracy of Ehteraz as a contact tracing App based on the WHO contact tracing criteria and compare its effectiveness to the traditional human led case investigation. Methods A cross-sectional study was conducted using two databases, including Ehteraz proximity data and swab collection and case investigations reports for the same period. Results 46.9% of contacts identified by the Ehteraz app did not meet WHO duration and distance criteria. Among the 5650 contacts flagged by Ehteraz during the period, 4973 (88.0%) of contacts did not share any known relation with the index case they are linked to. Conclusion The study highlighted the inaccuracy of the Ehteraz tool as its technology enables signals passing through walls, so people in different rooms could be unnecessarily flagged as having had contact. Big segments of the population (eg, Children) do not necessarily use smartphones and are not, therefore, flagged by Ehteraz digital contact tracing App. Similarly, Ehteraz rarely flags close contacts identified by human investigation as Bluetooth is usually turned off in a household or at a workplace. These findings highlight that digital contact tracing would be an efficient public health strategy when integrated to and complementing human investigation.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"2 1","pages":"255 - 260"},"PeriodicalIF":2.0,"publicationDate":"2022-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91159304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-05-01DOI: 10.1136/bmjinnov-2021-000887
Allan Ulitin, J. Mier-Alpaño, M. Labarda, N. Juban, Abigail Ruth Mier, J. Tucker, W. Tang, Mallika Auplish, P. Chan
Introduction Young people have played a pivotal role as part of the COVID-19 response, including developing health messages and social innovations. Social innovation in health engages multiple stakeholders in linking social change and health improvement. The study examined the feasibility of youth ideas and innovations to address the impacts of the COVID-19 pandemic using quantitative and qualitative descriptive analyses. Methods In partnership with the WHO, academic institutions, youth organisations and civil society groups, we conducted a crowdsourcing open call among Filipino youth (15–30 years old) using a structured Special Programme for Research and Training in Tropical Diseases/Social Innovation in Health Initiative process. The open call had three categories: youth voices to cocreate the post-COVID-19 world (entries were texts, images, videos and music), youth-led COVID-19 social innovations, and youth-led social innovations not related to COVID-19. Each submission was evaluated by three independent judges. Finalists were selected in each of the categories alongside four grand winners. All finalists were invited to attend a 1 day online civic hackathon. Results We received a total of 113 entries (youth voices to cocreate the post-COVID world=76; youth-led COVID-19 social innovations=17; youth-led social innovations not related to COVID-19=20). Twelve entries focused on youth mental health during the pandemic. The online hackathon provided the participants mentorship for further development of their ideas. Finalists were able to produce draft health communication campaigns and improved social innovations. Conclusion Many Filipino youth created exceptional entries in response to the open call. This suggests the feasibility of including youth voices in strategic planning processes. A global youth social innovation call is recommended.
{"title":"Youth social innovation during the COVID-19 pandemic in the Philippines: a quantitative and qualitative descriptive analyses from a crowdsourcing open call and online hackathon","authors":"Allan Ulitin, J. Mier-Alpaño, M. Labarda, N. Juban, Abigail Ruth Mier, J. Tucker, W. Tang, Mallika Auplish, P. Chan","doi":"10.1136/bmjinnov-2021-000887","DOIUrl":"https://doi.org/10.1136/bmjinnov-2021-000887","url":null,"abstract":"Introduction Young people have played a pivotal role as part of the COVID-19 response, including developing health messages and social innovations. Social innovation in health engages multiple stakeholders in linking social change and health improvement. The study examined the feasibility of youth ideas and innovations to address the impacts of the COVID-19 pandemic using quantitative and qualitative descriptive analyses. Methods In partnership with the WHO, academic institutions, youth organisations and civil society groups, we conducted a crowdsourcing open call among Filipino youth (15–30 years old) using a structured Special Programme for Research and Training in Tropical Diseases/Social Innovation in Health Initiative process. The open call had three categories: youth voices to cocreate the post-COVID-19 world (entries were texts, images, videos and music), youth-led COVID-19 social innovations, and youth-led social innovations not related to COVID-19. Each submission was evaluated by three independent judges. Finalists were selected in each of the categories alongside four grand winners. All finalists were invited to attend a 1 day online civic hackathon. Results We received a total of 113 entries (youth voices to cocreate the post-COVID world=76; youth-led COVID-19 social innovations=17; youth-led social innovations not related to COVID-19=20). Twelve entries focused on youth mental health during the pandemic. The online hackathon provided the participants mentorship for further development of their ideas. Finalists were able to produce draft health communication campaigns and improved social innovations. Conclusion Many Filipino youth created exceptional entries in response to the open call. This suggests the feasibility of including youth voices in strategic planning processes. A global youth social innovation call is recommended.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"48 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79981806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-26DOI: 10.1136/bmjinnov-2021-000869
O. Ekwunife, C. Onubogu, O. B. Aribodor, K. C. Anigbogu, U. Ogwaluonye, Chinyelu A Ekwunife, C. S. Okunna, O. Nwaorgu
Background Nigeria, the most populous country in Africa, is faced with several health challenges including neglected tropical diseases, non-communicable diseases and emerging infectious diseases. Unfortunately, the country has a weak health system to tackle these health challenges. Creative solutions for solving these systemic health challenges through social innovations are therefore needed in Nigeria. Hence, Social Innovation in Health Initiative (SIHI) Nigeria conducted a pilot crowdsourcing challenge to identify social innovation solutions in Anambra State, Nigeria. Method A crowdsourcing approach was used to identify social innovations in healthcare delivery that has been applied in Nigeria for a minimum of 1 year. The six-stage process of the crowdsourcing challenge contest included: (1) selection of challenge focus, (2) organising community steering group, (3) engaging the community to contribute, (4) receiving and evaluating contributions, (5) recognising finalists and (6) sharing solutions. The crowdsourcing challenge was hosted by SIHI Nigeria, based at the Nnamdi Azikiwe University, Awka, Nigeria. Result Seventeen innovations were received in the crowdsourcing challenge. Five of the innovations were eligible based on criteria developed and were sent to the panel of experts for review. Following the review of the average score and case study research, the panel of experts selected top three innovations, which included a digital health solution, a mobile clinic and a community-based health insurance programme. Conclusion Top three social innovations were identified in the crowdsourcing challenge. These innovations could be refined and scaled up to increase universal health coverage in Nigeria by subjecting them to further research.
{"title":"Approaching healthcare delivery through a new lens: a crowdsourcing challenge to identify health-related social innovations to increase universal health coverage in Nigeria","authors":"O. Ekwunife, C. Onubogu, O. B. Aribodor, K. C. Anigbogu, U. Ogwaluonye, Chinyelu A Ekwunife, C. S. Okunna, O. Nwaorgu","doi":"10.1136/bmjinnov-2021-000869","DOIUrl":"https://doi.org/10.1136/bmjinnov-2021-000869","url":null,"abstract":"Background Nigeria, the most populous country in Africa, is faced with several health challenges including neglected tropical diseases, non-communicable diseases and emerging infectious diseases. Unfortunately, the country has a weak health system to tackle these health challenges. Creative solutions for solving these systemic health challenges through social innovations are therefore needed in Nigeria. Hence, Social Innovation in Health Initiative (SIHI) Nigeria conducted a pilot crowdsourcing challenge to identify social innovation solutions in Anambra State, Nigeria. Method A crowdsourcing approach was used to identify social innovations in healthcare delivery that has been applied in Nigeria for a minimum of 1 year. The six-stage process of the crowdsourcing challenge contest included: (1) selection of challenge focus, (2) organising community steering group, (3) engaging the community to contribute, (4) receiving and evaluating contributions, (5) recognising finalists and (6) sharing solutions. The crowdsourcing challenge was hosted by SIHI Nigeria, based at the Nnamdi Azikiwe University, Awka, Nigeria. Result Seventeen innovations were received in the crowdsourcing challenge. Five of the innovations were eligible based on criteria developed and were sent to the panel of experts for review. Following the review of the average score and case study research, the panel of experts selected top three innovations, which included a digital health solution, a mobile clinic and a community-based health insurance programme. Conclusion Top three social innovations were identified in the crowdsourcing challenge. These innovations could be refined and scaled up to increase universal health coverage in Nigeria by subjecting them to further research.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"54 1","pages":"207 - 215"},"PeriodicalIF":2.0,"publicationDate":"2022-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86737558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-26DOI: 10.1136/bmjinnov-2021-000903
Shruti Murthy, P. Kamath, Myron Anthony Godinho, Nachiket Gudi, A. Jacob, Oommen John
Objective To identify and summarise the digital health interventions (DHIs) implemented for non-communicable disease (NCD) management for COVID-19. Design Rapid scoping review. Three reviewers jointly screened titles–abstracts and full texts. One reviewer screened all excluded records. Data were mapped to WHO DHI Classification and narratively summarised. Data sources PubMed, CENTRAL, CINAHL, EMBASE. Eligibility criteria for selecting studies Peer-reviewed primary research published between 1 November 2019 and 19 September 2021 on DHI for NCD management during the COVID-19 pandemic. Reviews, editorials, letters, commentaries, opinions, conference abstracts and grey literature were excluded. Results Eighty-three studies drawn from 5275 records were included. A majority of the studies were quantitative in design. Forty per cent of the DHIs were implemented in the Americas. Nearly half of these DHIs targeted mental health conditions. A majority of the interventions were delivered remotely and via telephones. Zoom (26.5%), email (17%) and WhatsApp (7.5%) were the top three platforms for care delivery. Telemedicine, targeted client interventions, personal health tracking and on-demand information services for clients were the most frequently implemented interventions. Details regarding associated costs, sustainability, scalability and data governance of the DHI implementations were not described in the majority of the studies. Conclusion While DHIs supported NCD management during the COVID-19 pandemic, their implementation has not been equitable across geographies or NCDs. While offering promise towards supporting the continuum of care during care delivery disruptions, DHIs need to be embedded into healthcare delivery settings towards strengthening health systems rather than standalone parallel efforts to overcome system level challenges.
{"title":"Digital health innovations for non-communicable disease management during the COVID-19 pandemic: a rapid scoping review","authors":"Shruti Murthy, P. Kamath, Myron Anthony Godinho, Nachiket Gudi, A. Jacob, Oommen John","doi":"10.1136/bmjinnov-2021-000903","DOIUrl":"https://doi.org/10.1136/bmjinnov-2021-000903","url":null,"abstract":"Objective To identify and summarise the digital health interventions (DHIs) implemented for non-communicable disease (NCD) management for COVID-19. Design Rapid scoping review. Three reviewers jointly screened titles–abstracts and full texts. One reviewer screened all excluded records. Data were mapped to WHO DHI Classification and narratively summarised. Data sources PubMed, CENTRAL, CINAHL, EMBASE. Eligibility criteria for selecting studies Peer-reviewed primary research published between 1 November 2019 and 19 September 2021 on DHI for NCD management during the COVID-19 pandemic. Reviews, editorials, letters, commentaries, opinions, conference abstracts and grey literature were excluded. Results Eighty-three studies drawn from 5275 records were included. A majority of the studies were quantitative in design. Forty per cent of the DHIs were implemented in the Americas. Nearly half of these DHIs targeted mental health conditions. A majority of the interventions were delivered remotely and via telephones. Zoom (26.5%), email (17%) and WhatsApp (7.5%) were the top three platforms for care delivery. Telemedicine, targeted client interventions, personal health tracking and on-demand information services for clients were the most frequently implemented interventions. Details regarding associated costs, sustainability, scalability and data governance of the DHI implementations were not described in the majority of the studies. Conclusion While DHIs supported NCD management during the COVID-19 pandemic, their implementation has not been equitable across geographies or NCDs. While offering promise towards supporting the continuum of care during care delivery disruptions, DHIs need to be embedded into healthcare delivery settings towards strengthening health systems rather than standalone parallel efforts to overcome system level challenges.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"18 1","pages":"3 - 18"},"PeriodicalIF":2.0,"publicationDate":"2022-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82498107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-25DOI: 10.1136/bmjinnov-2021-000865
Jennifer L Brown, K. Clegg Smith, K. Welding, J. Barnoya, Joanna E. Cohen
Brown JL, et al. BMJ Innov 2022;0:1–4. doi:10.1136/bmjinnov-2021-000865 Institute for Global Tobacco Control, Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA Departamento de Investigacion, Unidad de Cirugia Cardiovascular, Guatemala City, Guatemala Integra Cancer Institute, Guatemala City, Guatemala
Brown JL，等。中国生物医学工程学报(英文版);2009;01:1 - 4。doi:10.1136/ bmjinnovi -2021-000865全球烟草控制研究所，卫生、行为和社会系，约翰霍普金斯大学布隆伯格公共卫生学院，马里兰州巴尔的摩，美国卫生、行为和社会系，约翰霍普金斯大学布隆伯格公共卫生学院，马里兰州巴尔的摩，美国调查系，危地马拉Cirugia心血管研究所，危地马拉，危地马拉
{"title":"Innovations that harm: tobacco product and packaging in low-income and middle-income countries","authors":"Jennifer L Brown, K. Clegg Smith, K. Welding, J. Barnoya, Joanna E. Cohen","doi":"10.1136/bmjinnov-2021-000865","DOIUrl":"https://doi.org/10.1136/bmjinnov-2021-000865","url":null,"abstract":"Brown JL, et al. BMJ Innov 2022;0:1–4. doi:10.1136/bmjinnov-2021-000865 Institute for Global Tobacco Control, Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA Departamento de Investigacion, Unidad de Cirugia Cardiovascular, Guatemala City, Guatemala Integra Cancer Institute, Guatemala City, Guatemala","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"110 1","pages":"23 - 26"},"PeriodicalIF":2.0,"publicationDate":"2022-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76046242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-25DOI: 10.1136/bmjinnov-2021-000862
T. Crabtree, P. Choudhary, P. Kar, E. Wilmot
Just a few years ago FreeStyle Libre (FSL) was a rarely encountered device, used only by a select few people with type 1 diabetes who could afford to self-fund it. This small disc has a small cannula under the skin which allows for interstitial glucose measurements and remains in situ for 14 days. Over the last 4 years the number of people with access to this life-changing technology on the National Health Service (NHS) has increased rapidly. Although there were barriers to implementing access and encouraging uptake of this technology, including systems, healthcare professionals and the users themselves, innovative interventions from NHS England and diabetes organisations ensured those who stood to gain the most benefit were not impeded in their access, with a particular emphasis on enabling FSL use in those who are often the hardest to reach. This article reviews the impact of FSL on type 1 diabetes care in England, the key events to date and the lessons learnt that can be applied in the future for newer diabetes technologies.
{"title":"Flash glucose monitoring: the story so far and the journey ahead","authors":"T. Crabtree, P. Choudhary, P. Kar, E. Wilmot","doi":"10.1136/bmjinnov-2021-000862","DOIUrl":"https://doi.org/10.1136/bmjinnov-2021-000862","url":null,"abstract":"Just a few years ago FreeStyle Libre (FSL) was a rarely encountered device, used only by a select few people with type 1 diabetes who could afford to self-fund it. This small disc has a small cannula under the skin which allows for interstitial glucose measurements and remains in situ for 14 days. Over the last 4 years the number of people with access to this life-changing technology on the National Health Service (NHS) has increased rapidly. Although there were barriers to implementing access and encouraging uptake of this technology, including systems, healthcare professionals and the users themselves, innovative interventions from NHS England and diabetes organisations ensured those who stood to gain the most benefit were not impeded in their access, with a particular emphasis on enabling FSL use in those who are often the hardest to reach. This article reviews the impact of FSL on type 1 diabetes care in England, the key events to date and the lessons learnt that can be applied in the future for newer diabetes technologies.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"6 1","pages":"27 - 31"},"PeriodicalIF":2.0,"publicationDate":"2022-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77006658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-22DOI: 10.1136/bmjinnov-2021-000860
K. Thomson, K. Dangova, D. Bliss, S. Wallace, Nicole O’Connor, H. Richter, F. Pearson
Aim The aim of this study was to examine how new technologies in late-stage clinical trials might address unmet patient, practitioner or caregiver need for faecal incontinence (FI) over the next 5 years. Methods Horizon scanning techniques were used to provide insights into the current landscape of emerging health technologies. A search was performed across clinical trial registries using the National Institute for Health Research Innovation Observatory’s ScanMedicine database (scanmedicine.com) to identify new, emerging interventions or health technologies (drugs, medical devices or diagnostics) that were addressing or investigating FI. Trials were then screened for relevance to FI in a non-blinded duplicate manner. Results 1163 records were identified through searching ScanMedicine, and 136 trials were included in the final data extraction and mapping process. The most frequently investigated FI intervention topics were complementary therapies (n=17, 12.4%); electrical stimulation (n=13, 9.5%); pelvic floor muscle training/biofeedback/sphincter exercises (n=13, 9.5%) and implanted sacral nerve stimulation (n=12, 8.7%). There was little evidence of new pharmaceutical technologies in development. Existing drugs are, however, being repurposed and trialled for the treatment of FI (eg, linaclotide, colesevelam). Such repurposed drugs often have lower development costs, shorter timelines and report lower failure rates compared with new pharmaceutical products. Conclusion Overall, the innovation space as indicated by late-stage clinical trials related to FI, is relatively stagnant. Patients, carers and healthcare professionals are demanding more effective treatment and containment options; however, these are unlikely to come to market in the immediate future.
{"title":"Future developments and new technologies in the field of faecal incontinence: scanning the horizon using late-stage clinical trial registrations","authors":"K. Thomson, K. Dangova, D. Bliss, S. Wallace, Nicole O’Connor, H. Richter, F. Pearson","doi":"10.1136/bmjinnov-2021-000860","DOIUrl":"https://doi.org/10.1136/bmjinnov-2021-000860","url":null,"abstract":"Aim The aim of this study was to examine how new technologies in late-stage clinical trials might address unmet patient, practitioner or caregiver need for faecal incontinence (FI) over the next 5 years. Methods Horizon scanning techniques were used to provide insights into the current landscape of emerging health technologies. A search was performed across clinical trial registries using the National Institute for Health Research Innovation Observatory’s ScanMedicine database (scanmedicine.com) to identify new, emerging interventions or health technologies (drugs, medical devices or diagnostics) that were addressing or investigating FI. Trials were then screened for relevance to FI in a non-blinded duplicate manner. Results 1163 records were identified through searching ScanMedicine, and 136 trials were included in the final data extraction and mapping process. The most frequently investigated FI intervention topics were complementary therapies (n=17, 12.4%); electrical stimulation (n=13, 9.5%); pelvic floor muscle training/biofeedback/sphincter exercises (n=13, 9.5%) and implanted sacral nerve stimulation (n=12, 8.7%). There was little evidence of new pharmaceutical technologies in development. Existing drugs are, however, being repurposed and trialled for the treatment of FI (eg, linaclotide, colesevelam). Such repurposed drugs often have lower development costs, shorter timelines and report lower failure rates compared with new pharmaceutical products. Conclusion Overall, the innovation space as indicated by late-stage clinical trials related to FI, is relatively stagnant. Patients, carers and healthcare professionals are demanding more effective treatment and containment options; however, these are unlikely to come to market in the immediate future.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"1 1","pages":"278 - 284"},"PeriodicalIF":2.0,"publicationDate":"2022-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86457214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：